An expert panel of the country’s central drug authority has recommended granting emergency use authorisation to the Serum Institute of India’s COVID-19 vaccine Covovax and Biological E’s vaccine Corbevax with…
By Payal Banerjee, New Delhi An expert panel of the country’s central drug authority has recommended granting emergency use authorisation to Serum Institute of India’s COVID-19 vaccine Covovax and Biological…
The USFDA on Thursday issued an emergency use authorization (EUA) for MSD’s Covid-19 antiviral medication molnupiravir for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults who are at high…
Washington: Pfizer said Tuesday that clinical trials confirmed its Covid pill — a new type of treatment that should withstand the mutations seen with the Omicron variant — drastically reduced…
MSD and Ridgeback Biotherapeutics on Friday said its potential antiviral COVID-19 drug molnupiravir reduced the relative risk of hospitalization or death by 30% compared to placebo group. The analysis of…
MUMBAI: The subject expert committee (SEC) under India’s drug regulator is expected to review the EUA applications of drug companies seeking approval for Merck’s antiviral pill, Molnupiravir, on Thursday. Several…
Dr. Reddy’s Laboratories, one of a handful of Indian drug companies licensed to make a new COVID-19 pill developed by Merck, said on Monday it was open to making a…
We’ve waited 20 months for a medicine to blunt the coronavirus, and now two have appeared. Earlier this month, the UK medicines regulator approved molnupiravir, the COVID antiviral developed by…
MUMBAI: Sun Pharma said on Thursday it is gearing up to introduce antiviral Covid-19 drug, molnupiravir under the brand Molxvir at “an economical price” in India. Other companies including Hetero,…
Hyderabad-based Natco Pharma Limited and Hetero have sought marketing authorisation for their anti-Covid drug molnupiravir from the drug regulator, people in the know told ET. The Subject Expert Committee (SEC)…
